Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221903 · ClinicalTrials.gov registry record

The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA

A clinical trial of Burn and Regional Anesthesia, sponsored by University of Washington.

Recruiting
Registry status
10
Enrollment target
1
Study location

NCT07221903 is a study of Burn and Regional Anesthesia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 10 participants, below the 52-participant average among 8 other Burn trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221903, a study of Burn and Regional Anesthesia, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-10-22
Est. Completion 2026-12-31

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT07221903

The ClinicalTrials.gov registry entry for NCT07221903 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52-participant average among 8 other Burn trials with a reported enrollment target (81% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Burn appearing as the primary indexed condition, and to 0 interventions.

NCT07221903 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT07221903 about?

NCT07221903 is a clinical study titled "The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA". Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of l...

What is the current status of trial NCT07221903?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-10-22. Estimated completion is 2026-12-31.

What conditions does trial NCT07221903 study?

This clinical trial studies the following conditions: Burn, Regional Anesthesia, Skin Grafting.

Who is sponsoring clinical trial NCT07221903?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221903 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.